118 related articles for article (PubMed ID: 38695060)
21. Antitumor activity studies of iridium (III) polypyridine complexes-loaded liposomes against gastric tumor cell in vitro.
Xie FL; Huang ZT; Bai L; Zhu JW; Xu HH; Long QQ; Guo QF; Wu Y; Liu SH
J Inorg Biochem; 2021 Dec; 225():111603. PubMed ID: 34564032
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of liposome entrapped iridium(III) complexes toward SGC-7901 cells.
Chen Y; Gu Y; Hu H; Liu H; Li W; Huang C; Chen J; Liang L; Liu Y
J Inorg Biochem; 2023 Apr; 241():112134. PubMed ID: 36706490
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and photochemical properties of pH responsive tris-cyclometalated iridium(III) complexes that contain a pyridine ring on the 2-phenylpyridine ligand.
Nakagawa A; Hisamatsu Y; Moromizato S; Kohno M; Aoki S
Inorg Chem; 2014 Jan; 53(1):409-22. PubMed ID: 24341415
[TBL] [Abstract][Full Text] [Related]
24. Studies of anticancer activity in vivo and in vitro behaviors of liposomes encapsulated iridium(III) complex.
Gu Y; Wen H; Zhang Y; Bai L; Zhou Y; Zhang H; Tian L; Hao J; Liu Y
J Biol Inorg Chem; 2021 Feb; 26(1):109-122. PubMed ID: 33475857
[TBL] [Abstract][Full Text] [Related]
25. Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor.
Yang Y; Gao Y; Sun Y; Zhao J; Gou S
J Med Chem; 2023 Oct; 66(19):13731-13745. PubMed ID: 37788351
[TBL] [Abstract][Full Text] [Related]
26. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.
Wu N; Cao JJ; Wu XW; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Oct; 46(39):13482-13491. PubMed ID: 28951916
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and in vitro biological evaluation of three 4'-(4-methoxyphenyl)-2,2':6',2″-terpyridine iridium(III) complexes as new telomerase inhibitors.
Qin QP; Meng T; Tan MX; Liu YC; Luo XJ; Zou BQ; Liang H
Eur J Med Chem; 2018 Jan; 143():1387-1395. PubMed ID: 29126737
[TBL] [Abstract][Full Text] [Related]
28. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
[TBL] [Abstract][Full Text] [Related]
29. Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents.
Wang L; Yin H; Cui P; Hetu M; Wang C; Monro S; Schaller RD; Cameron CG; Liu B; Kilina S; McFarland SA; Sun W
Dalton Trans; 2017 Jun; 46(25):8091-8103. PubMed ID: 28604869
[TBL] [Abstract][Full Text] [Related]
30. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
31. Significant effects of counteranions on the anticancer activity of iridium(iii) complexes.
Zhang H; Guo L; Tian Z; Tian M; Zhang S; Xu Z; Gong P; Zheng X; Zhao J; Liu Z
Chem Commun (Camb); 2018 Apr; 54(35):4421-4424. PubMed ID: 29648559
[TBL] [Abstract][Full Text] [Related]
32. Aggregation-induced phosphorescence of iridium(III) complexes with 2,2'-bipyridine-acylhydrazone and their highly selective recognition to Cu2+.
Zhao N; Wu YH; Luo J; Shi LX; Chen ZN
Analyst; 2013 Feb; 138(3):894-900. PubMed ID: 23223311
[TBL] [Abstract][Full Text] [Related]
33. Antitumor Effects of Ir(III)-2
Panchangam RL; Rao RN; Balamurali MM; Hingamire TB; Shanmugam D; Manickam V; Chanda K
Inorg Chem; 2021 Dec; 60(23):17593-17607. PubMed ID: 34767343
[TBL] [Abstract][Full Text] [Related]
34. Cyclometalated iridium(III) bipyridyl-phenylenediamine complexes with multicolor phosphorescence: synthesis, electrochemistry, photophysics, and intracellular nitric oxide sensing.
Law WH; Leung KK; Lee LC; Poon CS; Liu HW; Lo KK
ChemMedChem; 2014 Jun; 9(6):1316-29. PubMed ID: 24643988
[TBL] [Abstract][Full Text] [Related]
35. Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
Wang FX; Chen MH; Hu XY; Ye RR; Tan CP; Ji LN; Mao ZW
Sci Rep; 2016 Dec; 6():38954. PubMed ID: 27958338
[TBL] [Abstract][Full Text] [Related]
36. An AIE Metal Iridium Complex: Photophysical Properties and Singlet Oxygen Generation Capacity.
Zhu W; Liu S; Wang Z; Shi C; Zhang Q; Wu Z; Li G; Zhu D
Molecules; 2023 Dec; 28(23):. PubMed ID: 38067643
[TBL] [Abstract][Full Text] [Related]
37. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes.
Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ
J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand.
Novohradsky V; Liu Z; Vojtiskova M; Sadler PJ; Brabec V; Kasparkova J
Metallomics; 2014 Mar; 6(3):682-90. PubMed ID: 24448555
[TBL] [Abstract][Full Text] [Related]
40. Complexes of Ir(III)-octaethylporphyrin with peptides as probes for sensing cellular O2.
Koren K; Dmitriev RI; Borisov SM; Papkovsky DB; Klimant I
Chembiochem; 2012 May; 13(8):1184-90. PubMed ID: 22532338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]